$PDYN
Palladyne AI Corp.

2023 Q2 Form 10-Q Financial Statement

#000095017023020582 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $1.277M $2.296M $743.0K
YoY Change -57.97% 209.02% -58.7%
Cost Of Revenue $943.0K $1.786M $488.0K
YoY Change -70.03% 265.98% -59.4%
Gross Profit $334.0K $510.0K $255.0K
YoY Change -409.26% 100.0% -57.29%
Gross Profit Margin 26.16% 22.21% 34.32%
Selling, General & Admin $12.66M $13.48M $20.00M
YoY Change -38.93% -32.63% 573.5%
% of Gross Profit 3791.02% 2642.35% 7844.31%
Research & Development $11.71M $9.403M $5.881M
YoY Change 54.66% 59.89% 108.92%
% of Gross Profit 3504.79% 1843.73% 2306.27%
Depreciation & Amortization $400.0K $400.0K $300.0K
YoY Change -55.56% 33.33% 200.0%
% of Gross Profit 119.76% 78.43% 117.65%
Operating Expenses $24.37M $22.88M $25.88M
YoY Change -15.61% -11.61% 347.43%
Operating Profit -$29.96M -$23.19M -$25.63M
YoY Change 3.37% -9.52% 394.01%
Interest Expense $874.0K $1.099M $11.00K
YoY Change 490.54% 9890.91% -99.92%
% of Operating Profit
Other Income/Expense, Net -$11.00K $1.049M $2.000K
YoY Change -100.27% 52350.0%
Pretax Income -$28.66M -$21.48M -$19.20M
YoY Change 15.91% 11.84% 269.41%
Income Tax $3.000K $0.00 $0.00
% Of Pretax Income
Net Earnings -$28.66M -$21.48M -$19.20M
YoY Change 23.97% 11.84% 269.41%
Net Earnings / Revenue -2244.32% -935.37% -2584.39%
Basic Earnings Per Share -$1.12 -$0.14 -$0.14
Diluted Earnings Per Share -$1.12 -$0.14 -$139.2K
COMMON SHARES
Basic Shares Outstanding 154.3M 154.3M 142.9M
Diluted Shares Outstanding 25.51M 152.8M 137.9M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.15M $94.72M $199.0M
YoY Change -50.81% -52.39% 51364.86%
Cash & Equivalents $25.57M $25.37M $199.0M
Short-Term Investments $49.58M $69.35M
Other Short-Term Assets $3.594M $5.046M $6.969M
YoY Change -34.8% -27.59% 1194.99%
Inventory $3.723M $6.058M $1.005M
Prepaid Expenses
Receivables $1.280M $2.314M $800.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $85.27M $110.5M $207.9M
YoY Change -48.05% -46.87% 22380.78%
LONG-TERM ASSETS
Property, Plant & Equipment $6.763M $7.634M $6.841M
YoY Change -13.02% 11.59%
Goodwill
YoY Change
Intangibles $17.48M $18.30M
YoY Change
Long-Term Investments
YoY Change
Other Assets $463.0K $481.0K $460.0K
YoY Change -7.95% 4.57% -99.83%
Total Long-Term Assets $35.40M $37.40M $7.301M
YoY Change -64.56% 412.27% -97.36%
TOTAL ASSETS
Total Short-Term Assets $85.27M $110.5M $207.9M
Total Long-Term Assets $35.40M $37.40M $7.301M
Total Assets $120.7M $147.9M $215.2M
YoY Change -54.29% -31.29% -22.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.597M $2.652M $1.629M
YoY Change 179.28% 62.8%
Accrued Expenses $4.049M $5.856M $3.867M
YoY Change -41.5% 51.44% 26.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.686M $9.404M $5.496M
YoY Change -0.95% 71.11% 80.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $6.000K
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $195.0K $651.0K $1.988M
YoY Change -96.24% -67.25% -91.49%
Total Long-Term Liabilities $195.0K $651.0K $1.988M
YoY Change -96.24% -67.25% -91.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.686M $9.404M $5.496M
Total Long-Term Liabilities $195.0K $651.0K $1.988M
Total Liabilities $21.62M $22.13M $14.77M
YoY Change 21.9% 49.85% -44.07%
SHAREHOLDERS EQUITY
Retained Earnings -$352.8M -$324.1M -$164.7M
YoY Change 96.79%
Common Stock $3.000K $15.00K $14.00K
YoY Change 7.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $99.05M $125.7M $200.4M
YoY Change
Total Liabilities & Shareholders Equity $120.7M $147.9M $215.2M
YoY Change -54.29% -31.29% -22.3%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$28.66M -$21.48M -$19.20M
YoY Change 23.97% 11.84% 269.41%
Depreciation, Depletion And Amortization $400.0K $400.0K $300.0K
YoY Change -55.56% 33.33% 200.0%
Cash From Operating Activities -$19.86M -$20.12M -$12.45M
YoY Change 28.38% 61.6% 221.67%
INVESTING ACTIVITIES
Capital Expenditures $273.0K $400.0K $514.0K
YoY Change -255.11% -22.18% -46.57%
Acquisitions
YoY Change
Other Investing Activities $20.39M $10.74M
YoY Change -118.67%
Cash From Investing Activities $20.12M $10.34M -$514.0K
YoY Change -118.39% -2111.28% -46.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -56.00K -7.000K -5.190M
YoY Change -93.47% -99.87% -385.32%
NET CHANGE
Cash From Operating Activities -19.86M -20.12M -12.45M
Cash From Investing Activities 20.12M 10.34M -514.0K
Cash From Financing Activities -56.00K -7.000K -5.190M
Net Change In Cash 198.0K -9.791M -18.16M
YoY Change -100.16% -46.07% 502.39%
FREE CASH FLOW
Cash From Operating Activities -$19.86M -$20.12M -$12.45M
Capital Expenditures $273.0K $400.0K $514.0K
Free Cash Flow -$20.14M -$20.52M -$12.97M
YoY Change 31.64% 58.28% 168.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
648000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001826681
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39897
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SARCOS TECHNOLOGY AND ROBOTICS CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2838301
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
650 South 500 West
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84101
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
927-7296
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154300000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25368000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35159000
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
69352000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
79337000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2314000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1866000
CY2023Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2321000
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4160000
CY2023Q1 us-gaap Inventory Net
InventoryNet
6058000
CY2022Q4 us-gaap Inventory Net
InventoryNet
3562000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5046000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5015000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
110459000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
129099000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7634000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7640000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18297000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19116000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10989000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11283000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
481000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
487000
CY2023Q1 us-gaap Assets
Assets
147860000
CY2022Q4 us-gaap Assets
Assets
167625000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2652000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3620000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5856000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6025000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
896000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
887000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9404000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10532000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12073000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12387000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
651000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
256000
CY2023Q1 us-gaap Liabilities
Liabilities
22128000
CY2022Q4 us-gaap Liabilities
Liabilities
23175000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
990000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154282881
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154282881
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154252704
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154252704
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
15000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
449772000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
447073000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
42000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-324097000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-302621000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
125732000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
144450000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147860000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
167625000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2296000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
743000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1786000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
488000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9403000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5881000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9735000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17792000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3741000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2211000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
819000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
25484000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
26372000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23188000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-25629000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1099000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11000
CY2023Q1 strc Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-436000
CY2022Q1 strc Gain Loss On Warrant Liability
GainLossOnWarrantLiability
6414000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1049000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21476000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19202000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21476000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19202000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152827729
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152827729
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137908690
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137908690
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-21476000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-19202000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
59000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21417000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19202000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
213962000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10850000
CY2022Q1 strc Shares Repurchased For Payment Of Tax Withholdings And Other Value
SharesRepurchasedForPaymentOfTaxWithholdingsAndOtherValue
-5250000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
65000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-19202000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
200425000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
144450000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2664000
CY2023Q1 strc Shares Repurchased For Payment Of Tax Withholdings And Other Value
SharesRepurchasedForPaymentOfTaxWithholdingsAndOtherValue
35000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-21476000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
125732000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21476000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19202000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2664000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10850000
CY2023Q1 us-gaap Depreciation
Depreciation
425000
CY2022Q1 us-gaap Depreciation
Depreciation
268000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
819000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
436000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6414000
CY2023Q1 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
694000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
448000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12000
CY2023Q1 strc Increase Decrease In Unbilled Receivables Under Changes In Operating Assets
IncreaseDecreaseInUnbilledReceivablesUnderChangesInOperatingAssets
-1840000
CY2022Q1 strc Increase Decrease In Unbilled Receivables Under Changes In Operating Assets
IncreaseDecreaseInUnbilledReceivablesUnderChangesInOperatingAssets
-62000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2496000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
32000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2233000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-300000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-143000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-986000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
403000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-160000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-603000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-314000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-181000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20122000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12452000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
400000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
514000
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
29262000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
40000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10338000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-514000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
65000
CY2023Q1 strc Shares Repurchased For Payment Of Tax Withholdings
SharesRepurchasedForPaymentOfTaxWithholdings
6000
CY2022Q1 strc Shares Repurchased For Payment Of Tax Withholdings
SharesRepurchasedForPaymentOfTaxWithholdings
5254000
CY2023Q1 strc Payment Of Obligations Under Capital Leases
PaymentOfObligationsUnderCapitalLeases
1000
CY2022Q1 strc Payment Of Obligations Under Capital Leases
PaymentOfObligationsUnderCapitalLeases
1000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5190000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9791000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18156000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35159000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217114000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25368000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198958000
CY2023Q1 strc Purchase Of Property And Equipment Included In Accounts Payable
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayable
58000
CY2021Q3 strc Right To Receive Exchange Ratio Of Common Stock
RightToReceiveExchangeRatioOfCommonStock
0.05129222424
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2023Q1 strc Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
94700000
CY2022Q4 strc Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
114500000
CY2023Q1 strc Retained Earning Accumlated Deficit
RetainedEarningAccumlatedDeficit
-324100000
CY2023Q1 strc Working Capital
WorkingCapital
101100000
CY2023Q1 us-gaap Revenues
Revenues
2296000
CY2022Q1 us-gaap Revenues
Revenues
743000
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
1866000
CY2022Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4160000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
62000
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
11000
CY2023Q1 strc Increase Decrease In Accounts Receivable Inclusive Of Accounts Receivable Acquired In Business Combination
IncreaseDecreaseInAccountsReceivableInclusiveOfAccountsReceivableAcquiredInBusinessCombination
448000
CY2023Q1 strc Increase Decrease Unbilled Receivable
IncreaseDecreaseUnbilledReceivable
-1839000
CY2023Q1 strc Increase Decrease In Contract Assets Current
IncreaseDecreaseInContractAssetsCurrent
48000
CY2023Q1 strc Increas Decrease In Contract Assets Long Term
IncreasDecreaseInContractAssetsLongTerm
-10000
CY2023Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
2314000
CY2023Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2321000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
110000
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1000
CY2022Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0
CY2022Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3800000
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
69352000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3276000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1996000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
79337000
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
253000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
69400000
CY2023Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3256000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2081000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1261000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
180000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1541000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1301000
CY2023Q1 us-gaap Inventory Net
InventoryNet
6058000
CY2022Q4 us-gaap Inventory Net
InventoryNet
3562000
CY2023Q1 us-gaap Inventory Adjustments
InventoryAdjustments
400000
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
400000
CY2023Q1 us-gaap Prepaid Insurance
PrepaidInsurance
2359000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3420000
CY2023Q1 strc Other Prepaid Expenses And Assets
OtherPrepaidExpensesAndAssets
1125000
CY2022Q4 strc Other Prepaid Expenses And Assets
OtherPrepaidExpensesAndAssets
404000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5046000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5015000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10685000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10266000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3051000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2626000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7634000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7640000
CY2023Q1 us-gaap Depreciation
Depreciation
400000
CY2022Q1 us-gaap Depreciation
Depreciation
300000
CY2023Q1 strc Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
4016000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2752000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4271000
CY2023Q1 strc Other Accrued Expenses And Current Liabilities
OtherAccruedExpensesAndCurrentLiabilities
3104000
CY2022Q4 strc Other Accrued Expenses And Current Liabilities
OtherAccruedExpensesAndCurrentLiabilities
1754000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5856000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6025000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21300000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3003000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18297000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2457000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3276000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3276000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18297000
CY2023Q1 strc Contingent Merger Consideration Earn Out Shares Remaining Issuable
ContingentMergerConsiderationEarnOutSharesRemainingIssuable
28125000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14263165
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.80
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7DT2H
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
698000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10046677
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.47
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
586561
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.29
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23723281
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.83
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
536000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8489185
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.58
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
698000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8378704
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.70
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
488000
CY2023Q1 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
4000000.0
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2664000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10850000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21476000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-19202000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152827729
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152827729
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137908690
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137908690
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82947405
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
62564533
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 strc Defined Contribution Plan Maximum Deferred Compensation By Employees Percentage
DefinedContributionPlanMaximumDeferredCompensationByEmployeesPercentage
1
CY2022 strc Defined Contribution Plan Maximum Deferred Compensation By Employees Percentage
DefinedContributionPlanMaximumDeferredCompensationByEmployeesPercentage
1

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
strc-20230331_def.xml Edgar Link unprocessable
0000950170-23-020582-index-headers.html Edgar Link pending
0000950170-23-020582-index.html Edgar Link pending
0000950170-23-020582.txt Edgar Link pending
0000950170-23-020582-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
strc-20230331.htm Edgar Link pending
strc-20230331.xsd Edgar Link pending
strc-ex31_1.htm Edgar Link pending
strc-ex31_2.htm Edgar Link pending
strc-ex32_1.htm Edgar Link pending
strc-ex32_2.htm Edgar Link pending
strc-20230331_lab.xml Edgar Link unprocessable
strc-20230331_cal.xml Edgar Link unprocessable
strc-20230331_pre.xml Edgar Link unprocessable
strc-20230331_htm.xml Edgar Link completed